GB0306070A
GB0306070D0
(en)
|
2003-03-17 |
2003-03-17 |
Organic compounds
|
ARP040100730A
AR043504A1
(en)
|
2003-03-17 |
2004-03-08 |
PHARMACEUTICAL COMPOSITIONS THAT INCLUDE RAPAMYCIN FOR THE TREATMENT OF INFLAMMATORY DISEASES
|
TW093106848A
TW200503703A
(en)
|
2003-03-17 |
2004-03-15 |
Pharmaceutical compositions
|
PE2004000273A
PE20050313A1
(en)
|
2003-03-17 |
2004-03-15 |
PHARMACEUTICAL COMPOSITION INCLUDING A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVE AND PIMECROLIMUS
|
TW097116133A
TW200835484A
(en)
|
2003-03-17 |
2004-03-15 |
Use of a combination of rapamycin or its derivative and pimecrolimus
|
KR1020057017469A
KR100855140B1
(en)
|
2003-03-17 |
2004-03-16 |
Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and immunologically-mediated diseases
|
BRPI0408423-3A
BRPI0408423A
(en)
|
2003-03-17 |
2004-03-16 |
pharmaceutical compositions comprising a combination of rapamycin or derivatives thereof and pimecrolimus for the treatment of immunologically and inflammatory mediated diseases
|
RU2005131996/15A
RU2005131996A
(en)
|
2003-03-17 |
2004-03-16 |
PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMBINATION OF RAPAMICINE OR ITS DERIVATIVE AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNO-MEDIATED DISEASES
|
US10/547,185
US20060154952A1
(en)
|
2003-03-17 |
2004-03-16 |
Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation-and ummunologically-mediated diseases
|
CN 200480005834
CN1756548A
(en)
|
2003-03-17 |
2004-03-16 |
Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and ummunologically-mediated diseases
|
PCT/EP2004/002714
WO2004082681A1
(en)
|
2003-03-17 |
2004-03-16 |
Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and ummunologically-mediated diseases
|
MYPI20040914A
MY137868A
(en)
|
2003-03-17 |
2004-03-16 |
Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation and ummunologically-mediated diseases
|
MXPA05009934A
MXPA05009934A
(en)
|
2003-03-17 |
2004-03-16 |
Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and ummunologically-mediated diseases.
|
JP2005518678A
JP2006515017A
(en)
|
2003-03-17 |
2004-03-16 |
Pharmaceutical composition comprising a combination of rapamycin or a derivative thereof and pimecrolimus for the treatment of inflammatory and immune mediated diseases
|
DE602004016830T
DE602004016830D1
(en)
|
2003-03-17 |
2004-03-16 |
PHARMACEUTICAL COMPOSITIONS COMPRISING A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVES AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY ENTIRE DISEASE (IBD)
|
EP04720871A
EP1608368B8
(en)
|
2003-03-17 |
2004-03-16 |
Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammatory bowel disease (ibd)
|
CA002633287A
CA2633287A1
(en)
|
2003-03-17 |
2004-03-16 |
Combinations of rapamycin or its derivatives and pimecrolimus for the treatment of inflammation- and immunologically-mediated diseases
|
AU2004222563A
AU2004222563B2
(en)
|
2003-03-17 |
2004-03-16 |
Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and immunologically-mediated diseases
|
PT04720871T
PT1608368E
(en)
|
2003-03-17 |
2004-03-16 |
Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammatory bowel disease (ibd)
|
AT04720871T
ATE409479T1
(en)
|
2003-03-17 |
2004-03-16 |
PHARMACEUTICAL COMPOSITIONS CONTAINING A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVES AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD)
|
PL04720871T
PL1608368T3
(en)
|
2003-03-17 |
2004-03-16 |
Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammatory bowel disease (ibd)
|
ES04720871T
ES2315648T3
(en)
|
2003-03-17 |
2004-03-16 |
PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVE AND PIMECROLIMUS FOR THE TREATMENT OF THE INFLAMMATORY DISEASE OF THE INTESTINE (IBD).
|
CL200400535A
CL2004000535A1
(en)
|
2003-03-17 |
2004-03-16 |
PHARMACEUTICAL COMPOSITION THAT INCLUDES RAPAMYCIN OR A DERIVATIVE OF RAPAMYCIN AND PIMECROLIMUS; AND ITS USE FOR THE TREATMENT OF INFLAMMATORY DISEASE OF THE INTESTINE.
|
CA002517671A
CA2517671A1
(en)
|
2003-03-17 |
2004-03-16 |
Combinations of rapamycin or its derivatives and pimecrolimus for the treatment of inflammation- and immunologically-mediated diseases
|
ZA200506372A
ZA200506372B
(en)
|
2003-03-17 |
2005-08-10 |
Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecroliums for the treatment of inflammation- and immunologically-mediated diseases
|
TNP2005000197A
TNSN05197A1
(en)
|
2003-03-17 |
2005-08-17 |
Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation -and immunologically- mediated diseases
|
EC2005006006A
ECSP056006A
(en)
|
2003-03-17 |
2005-09-08 |
PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF RAPAMYCIN OR ITS DERIVATIVE AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNOLOGICALLY MEDIATED DISEASES
|
HR20050800A
HRP20050800A2
(en)
|
2003-03-17 |
2005-09-12 |
Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and immunologically-mediated diseases
|
IS8028A
IS8028A
(en)
|
2003-03-17 |
2005-09-15 |
Medicinal preparations comprising the composition or derivative of rapamycin and pimecrolimus for the treatment of inflammatory and immune-mediated diseases
|
MA28526A
MA27671A1
(en)
|
2003-03-17 |
2005-09-30 |
PHARMACEUTICAL COMPOSITIONS COMPRISING A COMBINATION OF RAPAMYCIN OR DERIVATIVE THEREOF AND PIMECROLIMUS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNOLOGICALLY INDUCED DISEASES
|
NO20054778A
NO20054778L
(en)
|
2003-03-17 |
2005-10-17 |
Pharmaceutical compositions including a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammatory and immunologically mediated diseases
|
HK06106761.8A
HK1086743A1
(en)
|
2003-03-17 |
2006-06-13 |
Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammatory bowel disease (ibd)
|